Short answer
Azenta, Inc. (AZTA) filed its fiscal 2025 10-K annual report with the SEC on Dec 4, 2025. It reported revenue of $594M (−9.5% year over year) and net income of −$56M.
- Top risk flagged: Regulatory risk from potential misuse of synthetic gene products under genetic engineering restrictions narrowing gene synthesis markets
FY2025 key financial metrics · XBRL
- Revenue
- $594M
- −9.5% YoY
- Net income
- −$56M
- +66.0% YoY
- Operating margin
- -4.5%
- +26.1 pp YoY
- Gross margin
- 45.5%
- +5.4 pp YoY
- EPS (diluted)
- −$1.22
- +60.5% YoY
- ROE
- -3.2%
- +6.3 pp YoY
- Operating cash flow
- $72M
- +43.5% YoY
Source: XBRL data from the Azenta, Inc. (AZTA) FY2025 10-K on SEC EDGAR. USD.
Azenta, Inc. FY2025 10-K analysis
AI summary of each section, grounded in the filing text
Business Overview
- Core business model centered on life sciences sample management and genomic services technology relying on intellectual property rights
- Increased focus on managing risks from expiring patents starting 2025 through 2044, risking increased competition
- Entered Cooperation Agreement with Politan Capital Management LP, adding 3 board directors including Politan's Chief Investment Officer
- Stock price volatility notable, fluctuating between $25.03 and $67.51 per share in fiscal years 2024–2025
- Potential impacts from supply chain risks with some single-source suppliers and external service provider cybersecurity vulnerabilities
Management Discussion & Analysis
- Revenue details and YoY change not disclosed in provided MD&A excerpt
- Cash flow, buybacks, dividends, capex details absent in excerpt
- Forward-looking statements include risks and uncertainties, no specific guidance given
Risk Factors
- Regulatory risk from potential misuse of synthetic gene products under genetic engineering restrictions narrowing gene synthesis markets
- Geopolitical risk from US-China trade tensions and increased sales exposure to China (39% of revenue outside North America, growing China operations)
- Operational risk of disruptions at limited sample storage facilities exposed to natural disasters, e.g., two key facilities in tornado-prone Indianapolis
- Competitive risk from rapid technological changes requiring timely product introductions to avoid obsolescence amid competitors advancing new offerings
- Financial risk from $136 million cash held overseas with possible repatriation limits impacting capital deployment and liquidity management
Generated from the filing text; verify against the original. How to read a 10-K
Ask about this 10-K
Compare years, dig into a risk factor or check the numbers against insider trades and fund holders.